Abstract
RSV is a major cause of lower respiratory tract infections in children under two years old, leading to a high number of pneumonia and bronchiolitis cases. The rising number of infections poses a significant challenge to public health, particularly for hospitals and clinical facilities. To address this issue, it is crucial to explore effective treatments for RSV. Current treatment options …